In just over a year, histotripsy, the non-invasive ultrasound-based tumor-destroying treatment invented and developed at the University of Michigan, jumped from trial-stage hopeful to real-world therapy option that has benefited roughly 800 patients across the U.S. And the technology is already gaining footholds in other countries.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.